Acetazolamide
NDC 10135-830, Acetazolamide, tablet, from Marlex Pharmaceuticals, Inc..
- Product NDC
- 10135-830
- Status
- Listed
- Labeler
- Marlex Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA217197
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/10135-830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ACETAZOLAMIDE125 mg/1
Pharmacologic classes
Carbonic Anhydrase Inhibitor [EPC]; Carbonic Anhydrase Inhibitors [MoA]; Sulfonamides [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 10135-830-01 | 10135083001 | 100 TABLET in 1 BOTTLE (10135-830-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/4a03f35d-bfcb-77ff-e063-6294a90a4f06
Use it
Look up 10135-830 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/10135-830 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 10135-830. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.